Filter by: patients
What is Flurazepam?

Flurazapam is a benzodiazepine used for short-term treatment of insomnia.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Insomnia 10 5 Efficacy_major Efficacy_moderate Efficacy_slight
Sleeplessness 5 3 Efficacy_moderate Efficacy_slight
Other 2 1 Efficacy_cant_tell
Stiffness/Spasticity 2 0
Treat my mood condition(s) 1 1 Efficacy_none
Difficulty sleeping through night 1 0

See all 11 patients currently taking Flurazepam

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
2
Moderate
4
Mild
0
None
3

Reported Dosages

  15mg as needed 30mg as needed 15 mg daily 30 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 8 Number of Patients: 8  

Reported Stop Reasons

Why Patients Stopped Taking Flurazepam (multiple reasons could be selected)
Reason # Patients Percentage of patients
Doctor's advice 5   Doctor's advice: 50%
Side effects too severe 5   Side effects too severe: 50%
Did not seem to work 3   Did not seem to work: 30%
Course of treatment ended 2   Course of treatment ended: 20%

See all 10 patients who’ve stopped taking Flurazepam

Currently Taking Flurazepam

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0

Stopped Taking Flurazepam

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0

Reported Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Adherence of Flurazepam

Always
7 78%
Usually
1 11%
Sometimes
0 0%
Never
1 11%

Burden

Difficulty being on treatment

Burden of Flurazepam

Very
1 11%
Somewhat
2 22%
A little
0 0%
Not at all
6 67%

Cost

Paid out of pocket

Cost of Flurazepam

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
7 100%

See more information, including instructions, precautions, side effects, and interactions.

Report created on February 11, 2012.